Table 5.
Therapeutic Entity | Type of Fe NP | Application | References |
---|---|---|---|
Magnetic hyperthermia (MHT) | Superparamagnetic iron oxide nanoparticles | Normal cell restoration after cancer cell destruction | [48] |
OVA | Fe3O4-OVA | Tumour inhibition | [49] |
poly(lactic-co-glycolic acid) (PLGA) and chlorin E6 (Ce6) | Fe3O4-PLGA-Ce6 | Tumour cell ferroptosis | [50] |
DOX | DOX-Fe3O4 | Tumour lymph node detection and therapy | [51] |
Doxorubicin–Gelatin/Fe3O4–Alginate | DG/FA NPs | Targeted drug delivery and cancer therapy | [52] |